PT-2023-16005 · Proofpoint · Proofpoint Enterprise Protection

Ly1G3 · Published 2023-03-08 · Updated 2023-07-12 · CVE-2023-0090

Positive Technologies (AI Summary)

CVSS v3.1

9.8

Critical

Base vector

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Name of the Vulnerable Software and Affected Versions Proofpoint Enterprise Protection (PPS/POD) versions 8.20.0 and below

Description The webservices in Proofpoint Enterprise Protection contain a vulnerability that allows an anonymous user to execute remote code through 'eval injection'. Exploitation requires network access to the webservices API, but such access is a non-standard configuration.

Recommendations For versions 8.20.0 and below, consider restricting access to the webservices API to minimize the risk of exploitation. As a temporary workaround, consider disabling the eval injection functionality until a patch is available. At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Eval Injection

Code Injection

Weakness Enumeration

CWE-95

CWE-94

Related Identifiers

CVE-2023-0090

Affected Products

Proofpoint Enterprise Protection

References · 5

• https://nvd.nist.gov/vuln/detail/CVE-2023-0090 · Security Note
• https://proofpoint.com/security/security-advisories/pfpt-sa-2023-0001 · Vendor Advisory
• https://osv.dev/vulnerability/CVE-2023-0090 · Vendor Advisory
• https://t.me/cibsecurity/59660 · Telegram Post
• https://t.me/cvenotify/46209 · Telegram Post